Sirolimus and FTY720: new approaches to transplant immunosuppression.
Kahan
B D
BD
Division of Immunology and Organ Transplantation, University of Texas-Houston, USA.
D002986:Clinical Trials as Topic; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D011409:Propylene Glycols / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives; D014181:Transplantation Immunology / Q000187:drug effects
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; D020123:Sirolimus